EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported
THE EUROPEAN Medicines Agency (EMA) is investigating Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s health regulator flagged three